Table 3.

Comparison of incidence of all events between patients (n = 294) with postcontrast CIN and patients without CINa

Definition of CINOverall CIN Incidence (%)All AEsPb
CIN GroupNon-CIN Group
SCysC increase ≥15%24.825/60 (42%)47/182 (26%)0.02
ScysC increase ≥20%19.420/47 (43%)52/195 (27%)0.03
ScysC increase ≥25%16.118/39 (46%)54/203 (27%)0.01
SCr increase ≥0.3 mg/dl17.322/51 (43%)70/243 (29%)0.04
  • a AE, adverse event.

  • b P value from χ2 test.